Price Alert

enVVeno Medical Corporati... (NVNO)

NASDAQ: NVNO · Real-Time Price · USD

4.64

0.14 (3.11%)

At close: Aug 15, 2025, 12:36 PM

enVVeno Medical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	2.04M	2.94M	1.75M	17.91M	2.38M	2.31M	3.62M	4.95M	4.71M	2.27M	4.55M	2.9M	9.07M	51.34M	54.73M	57.9M	41.04M	43.84M
Short-Term Investments	33.1M	36M	41.4M	30.46M	36.69M	40.63M	42.79M	20.75M	25.04M	31.93M	34.49M	37.43M	28.41M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.4M	9.71M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	31K	31K	31K	31K	31K	31K	31K	66K	31K	31K	31K	34K	31K	31K	54.49K	-196.67K	34.99K	29.84K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	38K	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	462K	538K	581K	672K	469K	306K	511K	520K	352K	n/a	392K	381K	239K	312K	312.35K	310.05K	399.69K	328.84K
Total Current Assets	35.6M	39.48M	43.73M	49.05M	39.54M	43.25M	46.92M	26.22M	30.11M	34.52M	39.44M	40.71M	37.76M	51.65M	55.04M	58.21M	41.44M	44.17M
Property-Plant & Equipment	942K	1.07M	1.19M	1.31M	1.43M	1.55M	1.68M	1.81M	1.95M	2.06M	2.19M	2.32M	2.44M	2.54M	2.6M	910.77K	878.27K	859.29K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	251.16K	n/a	n/a
Total Long-Term Assets	973K	1.1M	1.22M	1.34M	1.46M	1.58M	1.71M	1.88M	1.98M	2.09M	2.23M	4.75M	12.17M	2.57M	2.66M	965.26K	913.26K	889.13K
Total Assets	36.58M	40.58M	44.95M	50.39M	40.99M	44.83M	48.63M	28.09M	32.09M	36.61M	41.66M	45.46M	49.93M	54.22M	57.7M	59.17M	42.35M	45.05M
Account Payables	1.07M	703K	1.01M	894K	698K	604K	427K	1.24M	1.3M	380K	648K	501K	1.03M	557K	560K	394.19K	308.88K	709.24K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	-427K	-1.24M	-1.3M	n/a	n/a	-308K	n/a	n/a	668.83K	33K	33K	n/a
Short-Term Debt	377K	370K	n/a	357K	351K	n/a	338K	331K	352K	n/a	n/a	308K	303K	297K	n/a	332.3K	312.7K	312.7K
Other Current Liabilities	936K	1.29M	725K	532K	166K	n/a	268K	29K	-67K	n/a	n/a	86K	71K	-3K	204.53K	-56.15K	135.75K	n/a
Total Current Liabilities	3.02M	1.66M	2.1M	2.23M	1.7M	1.49M	1.37M	2.03M	2.07M	1.17M	1.53M	1.3M	1.82M	1.27M	1.58M	1.12M	1.39M	1.87M
Long-Term Debt	505K	609K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-129	n/a	n/a	n/a
Total Long-Term Liabilities	505K	609K	700K	791K	882K	973K	1.06M	1.15M	1.21M	1.32M	1.4M	1.48M	1.56M	1.64M	1.71M	n/a	84.58K	169.16K
Total Liabilities	3.52M	2.27M	2.79M	3.02M	2.58M	2.46M	2.44M	3.18M	3.27M	2.48M	2.93M	2.79M	3.37M	2.91M	3.29M	1.12M	1.48M	2.04M
Total Debt	882K	979K	1.06M	1.15M	1.23M	1.32M	1.4M	1.48M	1.56M	1.64M	1.72M	1.79M	1.86M	1.93M	2.01M	332.3K	723.55K	802.1K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	95.00	95.00	85.00	85.00
Retained Earnings	-163.05M	-156.36M	-151.85M	-145.63M	-139.98M	-135.03M	-130.04M	-124.39M	-119.39M	-112.91M	-106.52M	-100.34M	-94.24M	-87.18M	-81.85M	-72.86M	-70.47M	-68.1M
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	n/a	0.00	n/a	0.00	0.00	0.00
Shareholders Equity	33.06M	38.31M	42.16M	47.37M	38.42M	42.37M	46.2M	24.91M	28.81M	34.13M	38.73M	42.67M	46.56M	51.32M	54.4M	58.05M	40.87M	43.01M
Total Investments	33.1M	36M	41.4M	30.46M	36.69M	40.63M	42.79M	20.75M	25.04M	31.93M	34.49M	39.83M	38.12M	n/a	n/a	n/a	n/a	n/a